Fortnightly Review: Disseminated intravascular coagulation: Diagnosis and treatment

BMJ

Volumn 312, Issue 7032, 1996, Pages 683-

  Baglin, Trevor ^a  

^a Department of Haematology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBIN; CYTOKINE; FOLIC ACID; GABEXATE MESILATE; HEPARIN; IMMUNOGLOBULIN M ANTIBODY; LEPIRUDIN; PLASMIN; PROTEIN C; THROMBIN; THROMBIN INHIBITOR; THROMBOPLASTIN; VITAMIN K GROUP;

BACTERIAL INFECTION; CAUSE OF DEATH; CLINICAL EXAMINATION; CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; GRAM NEGATIVE BACTERIUM; HEMOSTASIS; HUMAN; LABORATORY TEST; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; THROMBOCYTE; VASCULAR ENDOTHELIUM; VEIN THROMBOSIS;

DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; THROMBIN;

EID: 0029866673     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7032.683     Document Type: Article

References (28)

1. Hemker H. Thrombin generation, an essential step in haemostasis and thrombosis. In: Bloom A, Forbes C, Thomas D, Tuddenham E, eds. Haemostasis and thrombosis. Vol 1. New York: Churchill Livingstone, 1994: 477–90.
2. Esmon C. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. In: Meade T, ed. Bailliere's clinical haematology. Vol 7:3. London: Bailliere Tindall, 1994: 453–68.
3. Kreger E, Craven D, McCabe W. Gram-negative bacteraemia. IV. Reevaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344–55.
4. Gordon S, Hasiba U, Cross B, Poole M, Falanga A. Cysteine proteinase procoagulant from amnion-chorion. Blood 1985; 66: 1261–5.
5. Hamilton K, Hattori R, Esmon C, Sims P. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990; 265: 3809–14.
6. Mannucci P, Lubina G, Caocci L, Dioguardi N. Effect on blood coagulation of massive intravascular haemolysis. Blood 1969; 33: 207–13.
7. Bell W, Starksen N, Tong S, Porterfield J. Trousseau's syndrome: devastating coagulopathy in the absence of heparin. Am J Med 1985; 79: 423–30.
8. Williams E. Disseminated intravascular coagulation. In: Loscalzo J, Schafer A, eds. Thrombosis and hemorrhage. Boston: Blackwell Science, 1994: 921–44.
9. Marder V, Feinstein D, Francis C, Colman R. Consumptive thrombohemor-rhagic disorders. In: Colman R, Hirsh J, Marder V, Salzman E, eds. Hemostasis and thrombosis. 3rd ed. Philadelphia: JB Lippincott, 1994: 1023–63.
10. Mombelli G, Fiori G, Monotto R, Haeberli A, Straub P. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease. J Lab Clin Med 1993; 121: 83–90.
11. Williams E. Plasma a-2-antiplasmin activity: role in the evaluation and management of fibrinolytic states and other bleeding disorders. Arch Intern Med 1989; 149: 1769–72.
12. Latallo Z. Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes a multicenter trial. Thromb Haemost 1983; 50: 604–9.
13. Colman R. Formation of human plasma kinin. N Engl J Med 1974; 291: 509–15.
14. Warr T, Rao L, Rapaport S. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481–9.
15. Colman R, Robboy S, Minna J. Disseminated intravascular coagulation (DIC): an approach. Am J Med 1972; 52: 679–87.
16. Siegal T, Seligsohn U, Agahi E, Modan M. Clinical and laboratory aspects of DIC: A study of 118 cases. Thromb Haemost 1978; 39: 122–34.
17. Spero J, Lewis J, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 1980; 43: 28–33.
18. Richards E, Baglin T. Quantitation of reticulated platelets: methodology and clinical application. Br J Haematol 1995; 91: 445–51.
19. Carr J, McKinney M, McDonagh J. Diagnosis of disseminated intravascular coagulation. Role of D-dimer. Am J Clin Pathol 1989; 91: 280–7.
20. Alperin J. Coagulopathy caused by vitamin K deficiency in critically ill, hospitalised patients. JAMA 1987; 258: 1916–9.
21. Fenstein D. Diagnosis and management of disseminated intravascular coagulation: The role of heparin therapy. Blood 1982; 60: 284–7.
22. Hoyle C, Swirsky D, Freedman L, Hayhoe F. Beneficial effect of heparin in the management of patients with APL. Br J Haematol 1988; 68: 283–9.
23. Rodeghiero F, Avvisati G, Castaman G, Barbui T, Mandelli F. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood 1990; 75: 2112–7.
24. Harper P. The clinical use of antithrombin concentrate in septicaemia. Br J Hosp Med 1994; 52: 571–4.
25. Fourrier F, Chopin C, Huart J, Runge I, Caron C, Goudemand J. Doubleblind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104: 882–8.
26. Taylor F, Chang A, Esmon C, D'Angelo A, Vigano-D'Angelo S, Blick K. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918–25.
27. Saito M, Asakura H, Jokaji H, Uotani C, Kumabashiri I, Morishita E, et al. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy. Blood Coagul Fibrinolysis 1995; 6: 60–64.
28. Okamura T, Niho Y, Itoga T, Chiba S, Miyake M, Kotsuru M, et al. Treatment of disseminated intravascular coagulation and its prodromal stage with gabaxate mesilate (Foy): a multi-center trial. Acta Haematol 1993; 90: 120–4.